FTSE 100 Live 15 November: GDP disappoints, fresh GSK slump offsets Land Securities upgrade
Jitters over the health of the UK economy have been fuelled by today’s weaker-than-expected GDP release. September’s 0.1% ...
PipelineReview.com1h
Blenrep shows overall survival benefit in head-to-head DREAMM-7 phase III trial for relapsed/refractory multiple myeloma
LONDON, UK I 14, 2024 I GSK plc (LSE/NYSE: GSK) today announced positive headline results from a planned interim analysis of the DREAMM-7 ...
London open: Stocks fall as UK growth slows
London stocks fell in early trade on Friday as data showed that economic growth in the UK unexpectedly slowed in the third ...
GSK Raises Prospects For Withdrawn Blood Cancer Drug Blenrep To Return To US Market - Here's Why
On Thursday, GSK plc (NYSE:GSK) released headline results from a planned interim analysis of the DREAMM-7 head-to-head phase ...
Pharmabiz19h
GSK-sponsored survey reveals unique gaps in care and support facing patients with gynaecologic cancers
GSK plc announced the results of a GSK-sponsored multinational survey designed to raise awareness of challenges that people with gynaecologic cancers may experience. The survey, which was conducted by ...
This latest FTSE 100 dip could be an unmissable opportunity to pick up cut-price stocks
The FTSE 100 has pulled back with the government’s policy choices creating some negative sentiment. But this gives us a ...
GSK hails progress for withdrawn blood cancer drug
UK pharma group posts ‘statistically significant’ trial results for treatment combined with Blenrep pulled in 2022 ...